Case Report
Bilateral Pleural Effusions as an Initial Presentation in Primary Sjögren’s Syndrome
Table 1
Autoantibody and immunological profile.
| | Value | Normal value | Unit |
| Rheumatoid factor | 15 | 0–10 | IU/L | IgG | 2693 | 870–1700 | mg/dL | IgG4 | 35.4 | 4.8–105 | mg/dL | IgA | 525 | 110–410 | mg/dL | IgM | 194 | 33–190 | mg/dL | Antinuclear antibody | X320 | <40 | | Homogenous | X320 | — | | Speckled | X320 | — | | Anti-ds-DNA antibody | 10 | <12 | IU/mL | Anticardiolipin antibody (IgM) | 1.2 | <3.5 | IU/mL | Anticardiolipin antibody (IgG) | 8 | <10 | IU/mL | Lupus erythematosus test | Negative | — | | Lupus anticoagalant | 1.05 | <1.3 | sec | Preneutralization | 32.7 | — | sec | Postneutralization | 31.2 | — | sec | Antiribonucleoprotein antibody | Negative | — | | Anti-Sm antibody | Negative | — | | Anti-Sjögren’s syndrome-A antibody | X256 | — | | Anti-Sjögren’s syndrome-B antibody | Negative | — | | Proteinase-3 antineutrophil cytoplasmic antibody | <10 | <10 | EU | Myeloperoxidase antineutrophil cytoplasmic antibody | <10 | <20 | EU | Serum complement level | 40.8 | 25–48 | CH50/mL | C3 | 93 | 86–160 | mg/dL | C4 | 19 | 17–45 | mg/dL | Soluble interleukin 2 receptor | 1550 | 145–519 | IU/mL |
|
|